<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PACAP exerts neuroprotective effects under various neurotoxic conditions in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>In vivo, it reduces brain damage after global and transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The present study investigated whether PACAP has neuroprotective effects when applied before the <z:hpo ids='HP_0003674'>onset</z:hpo> of permanent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Rats were given bolus injections of PACAP38 intracerebroventricularly, and then underwent permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The results show that 2 microg of PACAP significantly reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> size measured 12 and 24h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>No further reduction was obtained by a 7-day pretreatment </plain></SENT>
<SENT sid="6" pm="."><plain>PACAP also ameliorated certain sensorimotor deficits </plain></SENT>
<SENT sid="7" pm="."><plain>Our present study provides further evidence for the neuroprotective effects of PACAP, and implies that it might be a promising preventive therapeutic agent in ameliorating ischemic brain damage </plain></SENT>
</text></document>